{"altmetric_id":1183125,"counts":{"readers":{"mendeley":5,"citeulike":0,"connotea":1},"blogs":{"unique_users_count":1,"unique_users":[495],"posts_count":1},"news":{"unique_users_count":1,"unique_users":["scientific_american"],"posts_count":2},"total":{"posts_count":3}},"citation":{"altmetric_jid":"4f6fa50a3cf058f610003160","authors":["Heidi Ledford"],"doi":"10.1038\/460021a","endpage":"21","first_seen_on":"2013-01-17T23:21:35+00:00","issns":["0028-0836","1476-4687"],"journal":"Nature","last_mentioned_on":1358877600,"links":["http:\/\/www.nature.com\/news\/2009\/090630\/full\/460021a.html"],"pmid":"19571851","pubdate":"2009-06-30T00:00:00+00:00","publisher":"Nature Publishing Group","scopus_subjects":["General"],"startpage":"21","subjects":["science"],"title":"Lawsuit puts flu-vaccine contract in doubt","type":"news","mendeley_url":"http:\/\/www.mendeley.com\/research\/lawsuit-puts-fluvaccine-contract-doubt"},"altmetric_score":{"score":16.536,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":16.536},"context_for_score":{"all":{"total_number_of_other_articles":3684317,"mean":4.9089888017246,"rank":166496,"this_scored_higher_than_pct":95,"this_scored_higher_than":3517803,"rank_type":"exact","sample_size":3684317,"percentile":95},"similar_age_3m":{"total_number_of_other_articles":280546,"mean":5.7207124703706,"rank":17608,"this_scored_higher_than_pct":93,"this_scored_higher_than":262936,"rank_type":"exact","sample_size":280546,"percentile":93},"this_journal":{"total_number_of_other_articles":34982,"mean":41.341189045482,"rank":11115,"this_scored_higher_than_pct":68,"this_scored_higher_than":23862,"rank_type":"exact","sample_size":34982,"percentile":68},"similar_age_this_journal_3m":{"total_number_of_other_articles":976,"mean":81.968582564103,"rank":581,"this_scored_higher_than_pct":40,"this_scored_higher_than":395,"rank_type":"exact","sample_size":976,"percentile":40}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":1,"Student  > Ph. D. Student":1,"Student  > Bachelor":2,"Professor":1},"by_discipline":{"Medicine and Dentistry":1,"Psychology":1,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":2}}},"geo":{"mendeley":{"DK":1}}},"posts":{"blogs":[{"title":"FDA approves recombinant flu vaccine","url":"http:\/\/blogs.nature.com\/news\/2013\/01\/fda-approves-recombinant-flu-vaccine.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+news%2Frss%2Fnewsblog+%28News+Blog+-+Blog+Posts%29","citation_ids":[1183124,1183125],"posted_on":"2013-01-17T19:49:00+00:00","summary":"The US Food and Drug Administration (FDA) has approved the first seasonal flu vaccine comprised of recombinant proteins, rather than inactivated or weakened virus.\nThe 16 January approval of Flublok, developed by Protein Sciences Corporation in Meriden, Co","author":{"name":"Nature News Blog","url":"http:\/\/blogs.nature.com\/news\/","description":""}}],"news":[{"title":"FDA Approves Recombinant Flu Vaccine","url":"http:\/\/www.scientificamerican.com\/article.cfm?id=fda-approves-recombinant-flu-vaccine","license":"public","citation_ids":[1183124,1183125],"posted_on":"2013-01-22T18:00:00+00:00","summary":"","author":{"name":"Scientific American","url":"http:\/\/www.scientificamerican.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/101\/normal\/scientific_american.png?1369846970"}},{"title":"FDA Approves Recombinant Flu Vaccine","url":"http:\/\/www.scientificamerican.com\/article.cfm?id=fda-approves-recombinant-flu-vaccine&print=true","citation_ids":[1183124,1183125],"posted_on":"2013-01-22T18:00:00+00:00","summary":"From   Nature  . [More]","author":{"name":"Scientific American","url":"http:\/\/www.scientificamerican.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/101\/normal\/scientific_american.png?1369846970"}}]}}